Envisagenics develops a predictive analytics platform for scientists to translate basic discoveries into therapies and reducing time to market for pharmaceutical companies. Its mission is to reduce the complexity of RNA-seq data into plausible candidates for drug and biomarker development.
Latest funding size
Time since last funding
|Grand Central Tech, Empire State Development, Gillian Sandler, National Institutes of Health, Accelerate Long Island, Third Kind Venture Capital, the Long Island Emerging technologies Fund (LIETF), Cosine, Dynamk Capital, Daniella Kranjac, The Thiel Foundation, Dolby Family Ventures, Shana Fisher, SV Angel|